Epidemiology
The most common malignant tumour of salivary glands, it constitutes 15.5% of all salivary gland tumours and 29% of all malignancies, occurring in both major and minor salivary glands2.
Histopathology
Mucoepidermoid carcinomas are composed of varying proportions of epidermoid, glandular, mucous and intermediate cells.
Immunohistochemistry
20/202 |
||
28/282 |
||
28/282 |
||
8/82 |
||
28/282 |
||
20/204, 44/62 (membranous staining of intermediate, clear and epidermoid cells, and luminal surface of glandular cells)3 |
||
13/63 (cytoplasmic staining of mucinous and non-specific cells)3 |
||
48/61 (membranous staining of intermediate, clear and epidermoid cells, and luminal surface of glandular cells)3 |
||
13/194, 43/63 (cytoplasmic staining of mucinous and non-specific cells)3 |
||
Differential diagnosis
High grade mucoepidermoid carcinoma:
squamous cell carcinoma. Mucoepidermoid carcinomas contain mucins, as demonstrated by Alcian blue or antibodies to MUC5AC.
Prognosis
There is a broad spectrum of aggressiveness. Outcome is dependent on tumour grade, margin status, location of the tumour and nodal status2. Negativity for MUC1 may be associated with a better prognosis3.
References
1 Chu, P. G. and L. M. Weiss (2002). "Keratin expression in human tissues and neoplasms." Histopathology 40(5): 403-39. (Summary data from multiple papers)
2 Perez-Ordonez B. Selected topics in salivary gland tumour pathology. Current Diagnostic Pathology2003;9:355-365.
4 Alos L, Lujan B, Castillo M. Expression of mucins (MUC1, MUC2, MUC5AC, MUC6) in mucoepidermoid carcinoma of salivary glands. Modern Pathology 2004;17:926 (abstract)
This page last revised 11.9.2005.
©SMUHT/PW Bishop